News16 Jan 2023 18:23
Diepenbeek, Belgium, January 13th, 2023 – Fox BIOSYSTEMS announces today that
they successfully closed on their funding round, raising €5.8M in new capital. Investors in
this round are Heran Partners, LRM, The Gemma Frisius Fund, KU Leuven, and
NetScientific.
FOX BIOSYSTEMS has developed an innovative Surface Plasmon Resonance (SPR)
technology using optical sensors. Their product, the White FOx, combines a microfluidicsfree
dip-in protocol for fast and user friendly SPR sensing. The unique approach of the
White FOx eliminates the risk of clogging and cross-contamination when using complex
samples such as lysates, whole blood or large particles. The sensor probes are available
with several generic surface chemistries and can be switched easily to allow the detection
of different target molecules, including antibodies, nanobodies, microvesicles, phages and
large particles, all with a single lab device.
A wide range of applications make the White FOx the ideal option for any life science or
biopharmaceutical research lab. Kinetic affinity analysis, label free biomolecule
quantification and fast specific and ultra-sensitive sandwich assays are all possible and
uniquely facilitate analysis of complex unpurified samples.
The additional raised capital will be used to scale up the company’s operations, accelerate
the development of new application areas, and to boost the commercialization of this
unique system.
Thomas van Elzakker, CEO of FOx BIOSYSTEMS: “We are very happy with the strong
support of our investors for our highly motivated team in realizing our vision for FOx
BIOSYSTEMS. They are confidently investing in our fast commercial growth today, while
also enabling us to deliver on our exciting innovation roadmap for tomorrow. The White
FOx system offers a solution to many of today’s analysis challenges, and it will continue
to be key in revealing new data and helping scientists to reach their goals more quickly.”
Katleen Vandersmissen, PhD, Chair of FOx BIOSYSTEMS and Managing Partner of HERAN
Partners: “With HERAN we try to spot those technologies and teams that can make a
difference and positive impact within the domain of Life Sciences. We believe that FOx,
now strongly backed by this financing round and the recent EIC grant, is up for success
based on their innovative take and ease of use on complex samples.”
About FOx Biosystems
FOx BIOSYSTEMS is a Belgian company with a mission to revolutionize the life sciences
and pharmacological research market with innovative real-time, label-free analysis
products. The basis of their success is a novel fiber-optic-based SPR biosensor which
enables users to generate high-quality, cost-effective biomolecular data fast, and over a
wide range of applications.
For more information visit www.foxbiosystems.com
Contact:
Mr. Kris Ver Donck, VP Marketing & Applications
info@foxbiosystems.com
About Heran Partners
Heran Partners is a Belgian-based MedTech an